Tocilizumab for Relapsing Polychondritis

Stopped Tocilizumab was licenced in Canada for children, so the study was not necessary

Conditions

• Relapsing Polychondritis

Interventions

• DRUG: Tocilizumab

Sponsor

McMaster Children's Hospital